This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab TrialGSK in breach for misleading prescription information on Omjjara: industry body
Granules India arm gets 1 USFDA observation for Hyderabad facilityLaurus Labs gets USFDA EIR for Atchutapuram facility
Shilpa Medicare arm, PPI to form new JV company in Saudi ArabiaBoehringer Ingelheim, Cue Biopharma partner to develop next generation treatment for autoimmune,...
Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatmentBristol Myers Squibb heart disease drug fails to meet main goals in late-stage study
Cipla arm Medispray Goa facility classified as VAI by USFDACipla gets CDSCO Panel nod for Phase-III CT of Inhaled Itraconazole dry powder for inhalation 10 mg...
Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCoMankind Pharma to constitute committee to evaluate ways to integrate BSV
Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance OfficerBiocon Biologics secures market entry date for ophthalmology drug Yesafili in US
AstraZeneca Pharma India surrenders marketing authorisation for specific indication of OlaparibAstraZeneca Pharma India surrenders marketing authorisation for specific indication of Olaparib
India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament ToldDelhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare...
Whos going to pay price to bring back manufacturing in US, asks Biocon MD"Who's going to pay price to bring back manufacturing in US", asks Biocon MD
Dr Reddys Labs gets USFDA EIR for Miryalaguda facilityRs 1 Cr Plus Earners in Firing Line as Dr Reddy's Targets 25% Cost Cut, May Shut Digital Unit
Pharmacists Must Now Mandatorily Verify Profiles with ABHA Number: PCIPCI Issues Special Inspection Guidelines for 2025-2026 academic session
X